PT 141 10mg per vial

PT 141 is a synthetic peptide analog of alpha-MSH. Administration of PT-141 to normal men and patients with erectile dysfunction resulted in a dose-dependent increase in erectile activity. The results suggest that PT-141 holds promise as a potential new treatment for sexual dysfunction. 

Furthermore, the Food and Drug Administration (FDA) has already approved PT 141 to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in women. HSDD is characterized by low sexual desire. It is not due to a co-existing medical or psychiatric condition.